Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting a site/app version change without modifying the underlying study record details.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision: v3.5.2 has been added, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the Locations list (Napoli removed; Naples added).SummaryDifference0.0%

- Check40 days agoChange DetectedA new Revision: v3.5.0 has been added and the previous Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; only a version tag change with no visible content changes.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 was added and the prior notices about government funding and operating status (v3.4.1) were removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.